Kelly Lawrence W & Associates Inc Sanofi Transaction History

Kelly Lawrence W & Associates Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$48.48 - $53.65 $3,635 - $4,023	-75 Reduced 20.0%	300 $15,000
Q2 2021 Aug 16, 2021	SELL	$49.36 - $54.25 $37,020 - $40,687	-750 Reduced 66.67%	375 $20,000
Q1 2021 May 17, 2021	BUY	$45.46 - $50.51 $47,733 - $53,035	1,050 Added 1400.0%	1,125 $56,000
Q4 2020 Feb 12, 2021	SELL	$45.3 - $51.62 $47,565 - $54,201	-1,050 Reduced 93.33%	75 $4,000
Q3 2020 Nov 13, 2020	SELL	$49.47 - $53.77 $7,420 - $8,065	-150 Reduced 11.76%	1,125 $57,000
Q4 2019 Feb 14, 2020	SELL	$44.25 - $50.86 $88,500 - $101,720	-2,000 Reduced 61.07%	1,275 $64,000
Q3 2019 Nov 14, 2019	SELL	$40.34 - $46.64 $6,051 - $6,996	-150 Reduced 4.38%	3,275 $152,000
Q2 2019 Aug 14, 2019	SELL	$40.43 - $44.3 $16,172 - $17,720	-400 Reduced 10.46%	3,425 $148,000
Q4 2017 Feb 14, 2018	SELL	$42.86 - $50.61 $8,572 - $10,122	-200 Reduced 4.97%	3,825 $164,000
Q3 2017 Nov 15, 2017	BUY	$47.04 - $50.34 $189,336 - $202,618	4,025	4,025 $200,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Kelly Lawrence W & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Kelly Lawrence W & Associates Inc with notifications on news.